← Back to Analyst Consensus 
AIM Buy
AIM ImmunoTech Inc.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 20, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Jun 1, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Apr 10, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 8, 2025 | Ascendiant Capital | maintain | Buy → Buy | $22 | 38% |
| Oct 3, 2025 | Ascendiant Capital | maintain | Buy → Buy | $24 | 38% |
| Dec 10, 2024 | Ascendiant Capital | maintain | Buy → Buy | $4.5 | 38% |
| Oct 22, 2024 | Maxim Group | maintain | Buy → Buy | $1 | 42% |
| Sep 3, 2024 | Ascendiant Capital | maintain | Buy → Buy | $5 | 38% |
| Oct 10, 2019 | Maxim Group | upgrade | Hold → Buy | $0 | 42% |
Price Target Trend
Jun 11, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days